265 related articles for article (PubMed ID: 25352204)
1. Mission critical: mobilization of essential animal models for Ebola, Nipah, and Machupo virus infections.
Zumbrun EE
Vet Pathol; 2015 Jan; 52(1):18-20. PubMed ID: 25352204
[TBL] [Abstract][Full Text] [Related]
2. Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat Cells.
Hoffmann M; Nehlmeier I; Brinkmann C; Krähling V; Behner L; Moldenhauer AS; Krüger N; Nehls J; Schindler M; Hoenen T; Maisner A; Becker S; Pöhlmann S
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429347
[TBL] [Abstract][Full Text] [Related]
3. Enhanced surveillance and response approaches for pilgrims and local Saudi populations against emerging Nipah, Zika and Ebola viral diseases outbreaks threats.
Tambo E; El-Dessouky AG; Khater EIM; Xianonng Z
J Infect Public Health; 2020 May; 13(5):674-678. PubMed ID: 32265162
[TBL] [Abstract][Full Text] [Related]
4. Review of Ebola virus infections in domestic animals.
Weingartl HM; Nfon C; Kobinger G
Dev Biol (Basel); 2013; 135():211-8. PubMed ID: 23689899
[TBL] [Abstract][Full Text] [Related]
5. Ebola virus circulation in Africa: a balance between clinical expression and epidemiological silence.
Gonzalez JP; Herbreteau V; Morvan J; Leroy EM
Bull Soc Pathol Exot; 2005 Sep; 98(3):210-7. PubMed ID: 16267963
[TBL] [Abstract][Full Text] [Related]
6. Development of experimental and early investigational drugs for the treatment of Ebola virus infections.
Wong G; Qiu X
Expert Opin Investig Drugs; 2015; 24(8):999-1011. PubMed ID: 26065319
[TBL] [Abstract][Full Text] [Related]
7. Experimental Respiratory Infection of Marmosets (Callithrix jacchus) With Ebola Virus Kikwit.
Smither SJ; Nelson M; Eastaugh L; Nunez A; Salguero FJ; Lever MS
J Infect Dis; 2015 Oct; 212 Suppl 2():S336-45. PubMed ID: 26209682
[TBL] [Abstract][Full Text] [Related]
8. High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system.
Lee N; Shum D; König A; Kim H; Heo J; Min S; Lee J; Ko Y; Choi I; Lee H; Radu C; Hoenen T; Min JY; Windisch MP
Antiviral Res; 2018 Oct; 158():226-237. PubMed ID: 30149038
[TBL] [Abstract][Full Text] [Related]
9. Progression of Ebola Therapeutics During the 2014-2015 Outbreak.
Mendoza EJ; Qiu X; Kobinger GP
Trends Mol Med; 2016 Feb; 22(2):164-173. PubMed ID: 26774636
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.
Oestereich L; Lüdtke A; Wurr S; Rieger T; Muñoz-Fontela C; Günther S
Antiviral Res; 2014 May; 105():17-21. PubMed ID: 24583123
[TBL] [Abstract][Full Text] [Related]
11. FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection.
Johansen LM; Brannan JM; Delos SE; Shoemaker CJ; Stossel A; Lear C; Hoffstrom BG; Dewald LE; Schornberg KL; Scully C; Lehár J; Hensley LE; White JM; Olinger GG
Sci Transl Med; 2013 Jun; 5(190):190ra79. PubMed ID: 23785035
[TBL] [Abstract][Full Text] [Related]
12. Ebola virus: unravelling pathogenesis to combat a deadly disease.
Hoenen T; Groseth A; Falzarano D; Feldmann H
Trends Mol Med; 2006 May; 12(5):206-15. PubMed ID: 16616875
[TBL] [Abstract][Full Text] [Related]
13. Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions.
Geisbert TW; Hensley LE
Expert Rev Mol Med; 2004 Sep; 6(20):1-24. PubMed ID: 15383160
[TBL] [Abstract][Full Text] [Related]
14. Animal models for ebolavirus countermeasures discovery: what defines a useful model?
Shurtleff AC; Bavari S
Expert Opin Drug Discov; 2015 Jul; 10(7):685-702. PubMed ID: 26004783
[TBL] [Abstract][Full Text] [Related]
15. Epidemics and Peptide Vaccine Response: A Brief Review.
Nandy A; Dey S; Roy P; Basak SC
Curr Top Med Chem; 2018; 18(26):2202-2208. PubMed ID: 30417788
[TBL] [Abstract][Full Text] [Related]
16. Ebola exposure, illness experience, and Ebola antibody prevalence in international responders to the West African Ebola epidemic 2014-2016: A cross-sectional study.
Houlihan CF; McGowan CR; Dicks S; Baguelin M; Moore DAJ; Mabey D; Roberts CH; Kumar A; Samuel D; Tedder R; Glynn JR
PLoS Med; 2017 May; 14(5):e1002300. PubMed ID: 28510604
[TBL] [Abstract][Full Text] [Related]
17. A single phosphorodiamidate morpholino oligomer targeting VP24 protects rhesus monkeys against lethal Ebola virus infection.
Warren TK; Whitehouse CA; Wells J; Welch L; Heald AE; Charleston JS; Sazani P; Reid SP; Iversen PL; Bavari S
mBio; 2015 Feb; 6(1):. PubMed ID: 25670780
[TBL] [Abstract][Full Text] [Related]
18. Enhancing preparation for large Nipah outbreaks beyond Bangladesh: Preventing a tragedy like Ebola in West Africa.
Donaldson H; Lucey D
Int J Infect Dis; 2018 Jul; 72():69-72. PubMed ID: 29879523
[TBL] [Abstract][Full Text] [Related]
19. Treatment of ebola virus disease.
Kilgore PE; Grabenstein JD; Salim AM; Rybak M
Pharmacotherapy; 2015 Jan; 35(1):43-53. PubMed ID: 25630412
[TBL] [Abstract][Full Text] [Related]
20. Antiviral effect of ranpirnase against Ebola virus.
Hodge T; Draper K; Brasel T; Freiberg A; Squiquera L; Sidransky D; Sulley J; Taxman DJ
Antiviral Res; 2016 Aug; 132():210-8. PubMed ID: 27350309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
